{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:22:53Z","timestamp":1762842173364,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":173,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.ctarc.2020.100187","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T03:40:39Z","timestamp":1593229239000},"page":"100187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction"],"prefix":"10.1016","volume":"24","author":[{"given":"Gabriella Alexandersson","family":"von D\u00f6beln","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Wagenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Holtved","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Birgitte","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Baeksgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ctarc.2020.100187_bib0001","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ncponc0796","article-title":"Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization","volume":"4","author":"Kleinberg","year":"2007","journal-title":"in Nat. Clin. Pract. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2020.100187_bib0002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2020.100187_bib0003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10120-011-0007-7","article-title":"Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis","volume":"14","author":"Montagnani","year":"2011","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100187_bib0004","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clon.2010.12.001","article-title":"Definitive chemoradiation for oesophageal cancer - a standard of care in patients with non-metastatic oesophageal cancer","volume":"23","author":"Gwynne","year":"2011","journal-title":"Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2020.100187_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1477-7819-11-278","article-title":"Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma","volume":"11","author":"Wang","year":"2013","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2020.100187_bib0006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/bjc.2015.179","article-title":"Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma","volume":"113","author":"Matthews","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100187_bib0007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"in N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2020.100187_bib0008","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1586\/era.09.113","article-title":"Cetuximab in metastatic or recurrent head and neck cancer: the extreme trial","volume":"9","author":"Rivera","year":"2009","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"15","key":"10.1016\/j.ctarc.2020.100187_bib0009","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","article-title":"Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status","volume":"29","author":"Van Cutsem","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2020.100187_bib0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2007.07.2325","article-title":"Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity","volume":"70","author":"Safran","year":"2008","journal-title":"in Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.ctarc.2020.100187_bib0011","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","article-title":"Classification of adenocarcinoma of the oesophagogastric junction","volume":"85","author":"Siewert","year":"1998","journal-title":"Br. J. Surg."},{"issue":"7","key":"10.1016\/j.ctarc.2020.100187_bib0012","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","article-title":"Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial","volume":"14","author":"Crosby","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2020.100187_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.2017.21","article-title":"Long-term results and recurrence patterns from SCOPE-1: a phase II\/III randomised trial of definitive chemoradiotherapy +\/- cetuximab in oesophageal cancer","author":"Crosby","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2020.100187_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.1598","article-title":"Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial","author":"Suntharalingam","year":"2017","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2020.100187_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.bjc.6601461","article-title":"Definitive chemoradiation in patients with inoperable oesophageal carcinoma","volume":"90","author":"Crosby","year":"2004","journal-title":"in Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2020.100187_bib0016","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.ctarc.2020.100187_bib0017","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"in JAMA"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100187_bib0018","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ijrobp.2004.05.056","article-title":"Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients","volume":"60","author":"Liao","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.ctarc.2020.100187_bib0019","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamaoto.2014.2013","article-title":"Primary radiotherapy compared with primary surgery in cervical esophageal cancer","volume":"140","author":"Cao","year":"2014","journal-title":"(in eng), JAMA Otolaryngol. Head Neck Surg."},{"issue":"6","key":"10.1016\/j.ctarc.2020.100187_bib0020","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdy105","article-title":"Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75\/08)","volume":"29","author":"Ruhstaller","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2020.100187_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12935-018-0594-z","article-title":"Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions","volume":"18","author":"Battaglin","year":"2018","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.ctarc.2020.100187_bib0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/08977194.2015.1010643","article-title":"Anti-epidermal growth factor receptor-targeted therapy in upper gastrointestinal tract cancers: a meta-analysis","volume":"33","author":"Li","year":"2015","journal-title":"Growth Factors"},{"issue":"2","key":"10.1016\/j.ctarc.2020.100187_bib0023","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00280-012-1898-7","article-title":"Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters","volume":"70","author":"Ku","year":"2012","journal-title":"Cancer Chemotherapy and Pharmacol."},{"issue":"20","key":"10.1016\/j.ctarc.2020.100187_bib0024","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003699","article-title":"Risk factors for esophageal fistula associated with chemoradiotherapy for locally advanced unresectable esophageal cancer a supplementary analysis of JCOG0303","volume":"95","author":"Tsushima","year":"2016","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100187_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10147-011-0192-8","article-title":"Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta","volume":"16","author":"Taniguchi","year":"2011","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2020.100187_bib0026","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"4_suppl","key":"10.1016\/j.ctarc.2020.100187_bib0027","article-title":"A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study","volume":"38","author":"C.C.Maarten","year":"2020","journal-title":"J. Clin. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294220300241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294220300241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:18:38Z","timestamp":1762841918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294220300241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":27,"alternative-id":["S2468294220300241"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2020.100187","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2020.100187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100187"}}